Lustig K D, Weisman G A, Turner J T, Garrad R, Shiau A K, Erb L
Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Ciba Found Symp. 1996;198:193-204; discussion 204-7. doi: 10.1002/9780470514900.ch11.
The cloning of a P2U purinoceptor cDNA has made it possible to use molecular biological approaches to investigate P2U purinoceptor function. Expression of recombinant P2U purinoceptors in mammalian cells lacking endogenous P2U purinoceptors has enabled us to characterize the receptor protein and its downstream effectors, and has allowed a partial analysis of the role of certain amino acid residues in ligand binding. These approaches have placed the pharmacological classification of the P2U purinoceptor on a firm molecular footing and have generated model systems that can be used to investigate receptor-ligand binding, regulation and signal transduction.
